Congenital dilated pupil warrants instant investigation

Article

The rare disease multisystemic smooth muscle dysfunction syndrome has a serious outcome

Gene mutation

The condition, caused by the mutation of the ACTA2 gene, is multisystemic smooth muscle dysfunction syndrome, which Dr Møller and colleagues investigated in three Danish children.1 "When we saw the first patient 15 years ago, we thought that the diagnosis was a variant of aniridia and the important thing to do would be to exclude the WAGR association and the risk of Wilms tumour," he continued. "However, this was not the case. We later discovered a lack of accommodation, a dilated aorta and cerebral signs and symptoms from vessel pathology in the brain and thus we realised the common pathophysiology had to be the smooth muscles."

Results and discussion

The occurrence of serious vascular and cardiac problems are not uncommon, he noted. "One of our patients died as a young teenager and one had a neurosurgical procedure for intra cerebral infarction. Furthermore, I have heard from colleagues abroad who saw similar cases that one of their young patients also died," he said.

"In fact, after publication of our cases, it has actually become apparent that the oldest patient has developed further changes in the retinal circulation. Therefore, it is mandatory to follow these patients in a medical retina clinic. This serious, life threatening disease, even though it is a very rare condition, needs urgent attention," he concluded.

Special contributor

Hans Ulrik Møller PhD, is a consultant ophthalmologist, paediatric ophthalmology at the Viborg/Aarhus Hospitals, Denmark. He can be contacted by Email: Hans.ulrik.moeller@viborg.rm.dk

Dr Møller has indicated that he has no financial disclosures relating to the content of this piece.

Reference

1. H.U. Møller et al., Br. J. Ophthalmol., 2012;96:1227–1231.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
© 2025 MJH Life Sciences

All rights reserved.